recall
savePark Avenue Compounding recall (Cls II)
November 26, 2025updated 5mo ago
community read0 votes
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1. — Reason: CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results. — Status: Ongoing
view source ↗Data sources
last refreshed 51m ago
Found something off?
same company · ±60 days · 6
- approvalNIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approvalNov 18, 2025
- device 510kMercator Medical (Thailand), Ltd. — Powder Free Nitrile Patient Examination Glove, Blue colored, Non-sterile Tested for Use with Chemotherapy Drugs and Fentanyl Citrate; Powder Free Nitrile Patient Examination Glove, Black colored, Non-sterile Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (510k cleared)Nov 17, 2025
- approvalARIPIPRAZOLE — FDA approvalNov 14, 2025
- approvalARIPIPRAZOLE — FDA approvalNov 14, 2025
- approvalestradiol ER: ESTRADIOL — FDA approvalDec 8, 2025
- approvalARIPIPRAZOLE — FDA approvalNov 14, 2025
🐶 often sniffed alongside
top 8- tagRecall26 co-mentions · 19 sources
- tagDrug Shortage9 co-mentions · 9 sources
- drugprazosin hydrochloride6 co-mentions · 3 sources
- drugISOTRETINOIN4 co-mentions · 2 sources
- drugAbsorica4 co-mentions · 2 sources
- drugmetoprolol succinate SR4 co-mentions · 4 sources
- drugmetoprolol succinate ER4 co-mentions · 4 sources
- drugZENATANE4 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that